News | October 02, 2013

U.S. Proton Therapy Outlook 2017

October 2, 2013 — Proton therapy is the most advanced radiation technique available. Unfortunately, access to proton therapy is limited due to the low number of proton therapy centers. Research institutes and hospitals are now frequently investing in proton therapy to make it more accessible to patients.

According to the "US Proton Therapy Outlook 2017" by RNCOS, the United States will be home to almost 27 proton therapy centers by 2017, almost double the current figure, and attain revenue of $1.17 billion. The 65-page report provides an insight into the demographics and historical trend (2008-2013) of cancer incidences, deaths and prevalence along with statewide and site-wide cancer incidences in the United States.

The study dedicates a complete chapter on the various components of any proton therapy center and covers issues related to accelerators, delivery, transportation, planning and positioning systems to human resources required to setup a center.

The report further provides the statewide statistics of potential patients for proton therapy and the latter's current market penetration. It also includes a section dedicated to market opportunity assessment, which would help service providers and vendors to extract benefits from the largely untapped but lucrative market.

After a thorough analysis of the market, RNCOS has deduced various trends, drivers and challenges that will have a major influence on shaping the growing market. On the competitive front, the report covers the current stand and its probable transformation by 2017 for service providers and equipment vendors. Additionally, the report provides analyses of equipment vendors as well as their business overviews, products and services and existing and planned installations in the United States until 2017.

For more information: www.rncos.com

Related Content

Videos | Radiation Therapy | February 20, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
Study Unveils Blueprint for Treating Radiation-Resistant Brain Tumor

NIH-funded researchers showed how gliomas may be treated with radiation and drugs that block DNA repair. Image courtesy of Castro lab, Michigan Medicine, Ann Arbor

 

News | Radiation Therapy | February 19, 2019
February 19, 2019 — Researchers at the University of Michigan recently searched for new brain tumor treatments by exp
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019
University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new...
Canon Adds Radiation Therapy Package to Aquilion Prime, Lightning CT Systems
News | Computed Tomography (CT) | February 11, 2019
In the patient-centric world of radiation oncology, it is critical that computed tomography (CT) simulation is...
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k) premarket notification...
University of Oklahoma Cancer Center Begins First Proton Therapy Treatments
News | Proton Therapy | February 01, 2019
Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...
Philips Collaborates With MIM Software on Radiation Therapy Treatment Planning
News | Treatment Planning | January 31, 2019
January 31, 2019 — Philips announced a collaboration with imaging solutions provider MIM Software Inc.
Videos | Lung Cancer | January 29, 2019
Gregory Videtic, M.D., staff physician in radiation oncology at the Cleveland Clinic, and David Johnstone, M.D., prof